rommelag: Market leader of BFS technology
Rudolf Geiss, General Manager, rommelag speaks about the company's investment in the development of products and services, as well…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Minimally invasive bone forming product ALLOB in Phase I/IIa trial for delayed union fracture
Bone Therapeutics, the regenerative therapy company addressing unmet medical needs in the field of bone diseases and orthopaedics,…
Queen’s scientist makes major cystic fibrosis breakthrough
A Queen’s University doctor has played a key role in a major breakthrough to change the lives of cystic fibrosis sufferers
FDA approves Lymphoseek for head and neck cancer determination
The most common side effects identified in clinical trial was pain or irritation at the injection site
FDA approves Afrezza to treat diabetes
The US Food and Drug Administration approved Afrezza (insulin human) Inhalation Powder, a rapid-acting inhaled insulin to improve…
FDA approves Beleodaq
The US Food and Drug Administration approved Beleodaq (belinostat) for the treatment of patients with peripheral T-cell lymphoma…
Will India’s IP law and policy ‘Modi-fy’?
Yogesh Pai, Assistant Professor of Law at National Law University, Delhi, says that greater certainty and predictability in IP law…
Healing the World
Express Pharma’s CSR Special spotlights initiatives beyond medicines that heal the world
Biogen Idec: Caring deeply
Biogen Idec prides itself in the business of transforming lives of patients. Corporate citizenship is deeply ingrained into the…
Boehringer Ingelheim India: Empowering changemakers
Innovation is intrinsic to human nature but very often, the impact of these remain restricted to a small circle. A…